Eosinophils mitigate intestinal fibrosis while promoting inflammation in a chronic DSS colitis model and co-culture model with fibroblasts

Inge Jacobs(KU Leuven), Bram Verstockt(Universitair Ziekenhuis Leuven), Séverine Vermeire(KU Leuven), Christine Breynaert(KU Leuven), Gianluca Matteoli(Rega Institute for Medical Research), Bo-Jun Ke(KU Leuven), Pieter Vanden Berghe(KU Leuven), Jonathan Cremer(KU Leuven), Tim Vanuytsel(Universitair Ziekenhuis Leuven), Ellen Dilissen(KU Leuven), S Deleu(KU Leuven), Tobie Martens(KU Leuven), Gert De Hertogh(KU Leuven)
Scientific Reports
November 7, 2024
10.1038/s41598-024-78602-0
Cited by 8

Related Papers

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
|Gut|2013|1.9k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k